IN8BIO, INC. financial data

Symbol
INAB on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 524% %
Debt-to-equity 36% %
Return On Equity -146% % 26%
Return On Assets -107% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,634,396 shares -94%
Common Stock, Shares, Outstanding 4,589,196 shares -90%
Entity Public Float $29,000,000 USD 28%
Common Stock, Value, Issued $10,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 4,537,683 shares 188%
Weighted Average Number of Shares Outstanding, Diluted 4,537,683 shares 188%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $11,157,000 USD -38%
General and Administrative Expense $9,895,000 USD -24%
Operating Income (Loss) $20,658,000 USD 35%
Net Income (Loss) Attributable to Parent $20,658,000 USD 35%
Earnings Per Share, Basic 7 USD/shares 81%
Earnings Per Share, Diluted 7 USD/shares 81%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current $346,000 USD 95%
Assets, Current $11,768,000 USD 76%
Property, Plant and Equipment, Net $2,103,000 USD -32%
Operating Lease, Right-of-Use Asset $2,039,000 USD -50%
Other Assets, Noncurrent $169,000 USD -48%
Assets $16,768,000 USD 5%
Accounts Payable, Current $204,000 USD -82%
Accrued Liabilities, Current $418,000 USD -46%
Liabilities, Current $1,703,000 USD -53%
Operating Lease, Liability, Noncurrent $1,812,000 USD -46%
Liabilities $3,579,000 USD -51%
Retained Earnings (Accumulated Deficit) $136,154,000 USD -18%
Stockholders' Equity Attributable to Parent $13,189,000 USD 54%
Liabilities and Equity $16,768,000 USD 5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,122,000 USD 61%
Net Cash Provided by (Used in) Financing Activities $3,893,000 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 490,000,000 shares 0%
Common Stock, Shares, Issued 4,589,196 shares -90%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $771,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,962,000 USD 157%
Deferred Tax Assets, Valuation Allowance $25,197,000 USD 28%
Deferred Tax Assets, Gross $26,240,000 USD 27%
Operating Lease, Liability $2,550,000 USD -40%
Depreciation $993,000 USD 3.7%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $3,137,000 USD -42%
Operating Lease, Liability, Current $738,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,019,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,217,000 USD -13%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $587,000 USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year Three $680,000 USD -44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $66,000 USD -93%
Additional Paid in Capital $149,333,000 USD 20%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $3,303,000 USD -39%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%